Clinical trial
An Open-Label Clinical Study to Assess the Performance of the Dialyzer With Endexo™ in End-Stage Renal Disease Subjects
NCT03536663 is registered in ClinicalTrials.gov with Fresenius Medical Care North America as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Clinical Study to Assess the Performance of the Dialyzer With Endexo™ in End-Stage Renal Disease Subjects
- Lead sponsor
- Fresenius Medical Care North America
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 29, 2018
- Completion date
- June 17, 2019
- Enrollment
- 23 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.